BioMarin Pharmaceutical | Capital Social Ordinario





Capital Social Ordinario Cambio Fecha
Acadia Pharmaceuticals USD 168.71M 104K 2025-09
Agios Pharmaceuticals USD 58.28M 241K 2025-09
Alnylam Pharmaceuticals USD 131.79M 130.49M 2025-09
Amgen USD 538M 300K 2025-09
Bayer EUR 982.42M 0 2025-09
Biogen USD 146.7M 200K 2025-09
BioMarin Pharmaceutical USD 192.1M 97K 2025-09
Gilead Sciences USD 1.24B 0 2025-09
Incyte USD 196.13M 2.01M 2025-09
Insmed USD 212.58M 210.76M 2025-09
Ionis Pharmaceuticals USD 161.14M 160.98M 2025-09
Moderna USD 391M 2M 2025-09
Neurocrine Biosciences USD 99.7M 700K 2025-09
PTC Therapeutics USD 79.93M 554K 2025-09
Regeneron Pharmaceuticals USD 105.3M 1.1M 2025-09
Roche Holding CHF 795.62M 699.54K 2025-12
Sarepta Therapeutics USD 104.77M 7.06M 2025-09
Ultragenyx Pharmaceutical USD 96.44M 88K 2025-09
United Therapeutics USD 42.9M 42.1M 2025-09
Vertex Pharmaceuticals USD 254M 2.29M 2025-09


BioMarin Pharmaceutical Capital Social Ordinario - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Feb 2026.